An overview of conceptual frameworks, analytical approaches of the barrett esophagus market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Barrett esophagus market is expected to grow with significant rate in the near future.
The global barrett esophagus market in 2020 is accounted for more than US$ xx Mn and expected to reach a value of US$ xx Mn by 2028 with a significant CAGR of 4.1%.
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
Barrett’s esophagus is a disorder, also known as Barrett's syndrome or columnar epithelium lined lower esophagus, in which there is an unusual variation in the interior lining of oesophagus (lower portion). The stomach cells (goblet cells) take the place of the cells of the esophagus (stratified squamous). This replacement of cells occurs due to the activity of stomach acids (chronic acids). The stomach acids are likely to leak into the food pipe or esophagus, if the enclosure of muscles at the lower part of oesophagus does not close firmly, which may cause harm to the esophageal cells over time and may result in Barrett’s esophagus.
The common signs and symptoms of Barrett Esophagus are similar to that of Gastroesophageal reflux disease (GERD) that is dysphagia, heartburn, sensation of a lump in the throat, acid reflux, dry cough, and chest pain. Generally this disease is diagnosed with the help of biopsy and endoscopy. Once the disease is diagnosed, patients are prescribed for the intake of acid-suppressing medications, also known as proton pump inhibitors.
There are different acid-suppressing medications patients could intake including pantoprazole, omeprazole, lansoprazole, esomeprazole, and rabeprazole. The medical care of Barrett Esophagus may also involve surgeries that include ablative therapies (radiofrequency ablation, photodynamic therapy), mucosal resection and esophagectomy. The patients are also usually advised to make dietary changes to reduce the risk of Barrett’s esophagus. This can be achieved by escalating the intake of vitamins, vegetables, and fruits.
The growing prevalence of Barrett Esophagus or Barrett’s Syndrome among the masses across the world is one of the major factors that is boosting the growth of the global barrett esophagus market. As per the estimates, approximately 1.6% to 6.8% of the total global population suffers from the disease every year till date and this share is projected to escalate over the forecast period. In addition to that, there are also a rising number of patients suffering from GERD which further elevates the risk of Barrett’s esophagus, thereby propelling the growth of the global Barrett's esophagus market in the forthcoming years.
Furthermore, the rising count of surgical interventions and procedures in different disease conditions is also playing a positive role in providing significant growth opportunities for the global Barrett Esophagus market in the coming years.
Rising incidence related to esophageal diseases is major factor driving growth of the global barrett esophagus market across the globe. Also increasing number of patients suffering from gastro esophagus reflux disease (GERD) that increases the risk of barrett’s esophagus will propel growth of the global market over the forecast period. Increasing changes in the lifestyle are leading to increasing consumption of alcohol causing GERD among people and obesity are expected to drive the growth barrett’s esophagus market globally. According to data published by World Health Organization (WHO), in 2018, alcohol consumption leads to 3 Mn deaths each year globally as well as to the disabilities and poor health of millions of people. In addition, 9.6 Mn people worldwide are accounted to die from cancer in 2018. However, the asymptomatic condition of barrett’s esophagus, patent expiry of drugs employed for the treatment of GERD, and the availability of over-the counter drugs are some of the factor which are expected to act as a barrier in the growth of the global barrett esophagus market in the near future. Nevertheless, growing number of surgical procedures and surgical interventions in various disease conditions are expected to create immense growth opportunities for the global postoperative pain management market over the forecast period.
Global barrett esophagus market is segmented on the basis of treatment, distribution channel, and by region.
Medications
Proton Pump Inhibitors
Antacids
H2 Blockers
Promotility Agents
Others
Surgical Treatment
Radiofrequency Ablation
Photodynamic Therapy
Endoscopic Spray Cryotherapy
Endoscopic Mucosal Resection
Surgery
Hospital Pharmacies
Retail Pharmacies
Over The Counter
Others
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Endoscopy and biopsy are main processes which helps to diagnosed Barrett’s esophagus syndrome. After the diagnosis of disease in patient body, patients are prescribed for proton pump inhibitors in which uptake of acid-suppressing medications is done. Omeprazole, pantoprazole, lansoprazole, esomeprazole, and rabeprazole are some of the various drugs which includes in proton pump inhibitors. Healthcare experts also recommend surgery for the treatment of barrett’s esophagus complication which includes ablative therapies i.e. radiofrequency ablation and photodynamic therapy, and esophagectomy and mucosal resection. Risk of barrett’s esophagus can be avoided with the help of dietary changes with the help of increasing intake of more vegetables, vitamins and fruits in person’s regular meals for the day.
Barrett's esophagus can be classified into three categories:
Source: Drugbank, 2018
Some of the key participating players in global barrett esophagus market are Addex Therapeutics, AstraZeneca, Plc., Rottapharm (Meda AB), Takeda Pharmaceutical Company Limited, Eisai Co. Ltd., Pfizer, Inc., Torax Medical, Mederi Therapeutics, Aros Pharma, Torax Medical, Inc., and C. R. Bard.
On the basis of region, the barrett esophagus market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
1. Global Barrett Esophagus Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Barrett Esophagus Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Barrett Esophagus Market Snapshot
2.4. Global Barrett Esophagus Market Size and Forecast, 2019–2027
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)
2.5. Global Barrett Esophagus Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Barrett Esophagus Market, By Treatment
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Treatment
3.1.2. BPS Analysis, By Treatment
3.2. Market Revenue (US$Mn) Forecast, By Treatment
3.2.1. Medications
3.2.1.1. Proton Pump Inhibitors
3.2.1.2. Antacids
3.2.1.3. H2 Blockers
3.2.1.4. Promotility Agents
3.2.1.5. Others
3.2.2. Surgical Treatment
3.2.2.1. Radiofrequency Ablation
3.2.2.2. Photodynamic Therapy
3.2.2.3. Endoscopic Spray Cryotherapy
3.2.2.4. Endoscopic Mucosal Resection
3.2.2.5. Surgery
3.3. Global Barrett Esophagus Market Attractiveness Index, By Treatment
4. Global Barrett Esophagus Market, By Distribution Channel
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Distribution Channel
4.1.2. BPS Analysis, By Distribution Channel
4.2. Market Revenue (US$Mn) Forecast, By Distribution Channel
4.2.1. Hospital Pharmacies
4.2.2. Retail Pharmacies
4.2.3. Over The Counter
4.2.4. Others
5. Global Barrett Esophagus Market, By Region
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Region
5.1.2. BPS Analysis, By Region
5.2. Market Revenue (US$Mn) Forecast, By Region
5.2.1. North America
5.2.2. Latin America
5.2.3. Europe
5.2.4. Asia Pacific
5.2.5. Middle East
5.2.6. Africa
5.3. Global Barrett Esophagus Market Attractiveness Index, By Region
6. North America Barrett Esophagus Market Analysis and Forecast, 2019–2027
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Country
6.1.2. BPS Analysis, By Country
6.2. Market Revenue (US$Mn) Forecast, By Country
6.2.1. U.S. Barrett Esophagus Market
6.2.2. Canada Barrett Esophagus Market
6.3. North America Barrett Esophagus Market, By Treatment
6.3.1. Medications
6.3.1.1. Proton Pump Inhibitors
6.3.1.2. Antacids
6.3.1.3. H2 Blockers
6.3.1.4. Promotility Agents
6.3.1.5. Others
6.3.2. Surgical Treatment
6.3.2.1. Radiofrequency Ablation
6.3.2.2. Photodynamic Therapy
6.3.2.3. Endoscopic Spray Cryotherapy
6.3.2.4. Endoscopic Mucosal Resection
6.3.2.5. Surgery
6.4. North America Barrett Esophagus Market, By Distribution Channel
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Over The Counter
6.4.4. Others
6.5. North America Barrett Esophagus Market Attractiveness Index
6.5.1. By Country
6.5.2. By Distribution Channel
6.5.3. By Treatment
7. Latin America Barrett Esophagus Market Analysis and Forecast, 2019–2027
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market (US$Mn) Forecast, By Country
7.2.1. Brazil Barrett Esophagus Market
7.2.2. Mexico Barrett Esophagus Market
7.2.3. Argentina Barrett Esophagus Market
7.2.4. Rest of Latin America Barrett Esophagus Market
7.3. Latin America Barrett Esophagus Market, By Treatment
7.3.1. Medications
7.3.1.1. Proton Pump Inhibitors
7.3.1.2. Antacids
7.3.1.3. H2 Blockers
7.3.1.4. Promotility Agents
7.3.1.5. Others
7.3.2. Surgical Treatment
7.3.2.1. Radiofrequency Ablation
7.3.2.2. Photodynamic Therapy
7.3.2.3. Endoscopic Spray Cryotherapy
7.3.2.4. Endoscopic Mucosal Resection
7.3.2.5. Surgery
7.4. Latin America Barrett Esophagus Market, By Distribution Channel
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Over The Counter
7.4.4. Others
7.5. Latin America Barrett Esophagus Market Attractiveness Index
7.5.1. By Country
7.5.2. By Distribution Channel
7.5.3. By Treatment
8. Europe Barrett Esophagus Market Analysis and Forecast, 2019–2027
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. U.K. Barrett Esophagus Market
8.2.2. Germany Barrett Esophagus Market
8.2.3. Italy Barrett Esophagus Market
8.2.4. France Barrett Esophagus Market
8.2.5. Spain Barrett Esophagus Market
8.2.6. Russia Barrett Esophagus Market
8.2.7. Poland Barrett Esophagus Market
8.2.8. BENELUX Barrett Esophagus Market
8.2.9. NORDIC Barrett Esophagus Market
8.2.10. Rest of Europe Barrett Esophagus Market
8.3. Europe Barrett Esophagus Market, By Treatment
8.3.1. Medications
8.3.1.1. Proton Pump Inhibitors
8.3.1.2. Antacids
8.3.1.3. H2 Blockers
8.3.1.4. Promotility Agents
8.3.1.5. Others
8.3.2. Surgical Treatment
8.3.2.1. Radiofrequency Ablation
8.3.2.2. Photodynamic Therapy
8.3.2.3. Endoscopic Spray Cryotherapy
8.3.2.4. Endoscopic Mucosal Resection
8.3.2.5. Surgery
8.4. Europe Barrett Esophagus Market, By Distribution Channel
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Over The Counter
8.4.4. Others
8.5. Europe Barrett Esophagus Market Attractiveness Index
8.5.1. By Country
8.5.2. By Distribution Channel
8.5.3. By Treatment
9. Asia Pacific Barrett Esophagus Market Analysis and Forecast, 2019–2027
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. China Barrett Esophagus Market
9.2.2. India Barrett Esophagus Market
9.2.3. Japan Barrett Esophagus Market
9.2.4. Australia and New Zealand Barrett Esophagus Market
9.2.5. South Korea Barrett Esophagus Market
9.2.6. ASEAN Barrett Esophagus Market
9.2.7. Rest of Asia Pacific Barrett Esophagus Market
9.3. Asia Pacific Barrett Esophagus Market, By Treatment
9.3.1. Medications
9.3.1.1. Proton Pump Inhibitors
9.3.1.2. Antacids
9.3.1.3. H2 Blockers
9.3.1.4. Promotility Agents
9.3.1.5. Others
9.3.2. Surgical Treatment
9.3.2.1. Radiofrequency Ablation
9.3.2.2. Photodynamic Therapy
9.3.2.3. Endoscopic Spray Cryotherapy
9.3.2.4. Endoscopic Mucosal Resection
9.3.2.5. Surgery
9.4. Asia Pacific Barrett Esophagus Market, By Distribution Channel
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Over The Counter
9.4.4. Others
9.5. Asia Pacific Barrett Esophagus Market Attractiveness Index
9.5.1. By Country
9.5.2. By Treatment
10. Middle East Barrett Esophagus Market, By Region
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. GCC Countries Barrett Esophagus Market
10.2.2. Israel Barrett Esophagus Market
10.2.3. Oman Barrett Esophagus Market
10.2.4. Rest of Middle East Barrett Esophagus Market
10.3. Middle East Barrett Esophagus Market, By Treatment
10.3.1. Medications
10.3.1.1. Proton Pump Inhibitors
10.3.1.2. Antacids
10.3.1.3. H2 Blockers
10.3.1.4. Promotility Agents
10.3.1.5. Others
10.3.2. Surgical Treatment
10.3.2.1. Radiofrequency Ablation
10.3.2.2. Photodynamic Therapy
10.3.2.3. Endoscopic Spray Cryotherapy
10.3.2.4. Endoscopic Mucosal Resection
10.3.2.5. Surgery
10.4. Middle East Barrett Esophagus Market, By Distribution Channel
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Over The Counter
10.4.4. Others
10.5. Middle East Barrett Esophagus Market Attractiveness Index
10.5.1. By Country
10.5.2. By Distribution Channel
10.5.3. By Treatment
11. Africa Barrett Esophagus Market, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. South Africa Barrett Esophagus Market
11.2.2. Egypt Barrett Esophagus Market
11.2.3. North Africa Barrett Esophagus Market
11.2.4. Rest of Africa Barrett Esophagus Market
11.3. Africa Barrett Esophagus Market, By Treatment
11.3.1. Medications
11.3.1.1. Proton Pump Inhibitors
11.3.1.2. Antacids
11.3.1.3. H2 Blockers
11.3.1.4. Promotility Agents
11.3.1.5. Others
11.3.2. Surgical Treatment
11.3.2.1. Radiofrequency Ablation
11.3.2.2. Photodynamic Therapy
11.3.2.3. Endoscopic Spray Cryotherapy
11.3.2.4. Endoscopic Mucosal Resection
11.3.2.5. Surgery
11.4. Africa Barrett Esophagus Market, By Distribution Channel
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Over The Counter
11.4.4. Others
11.5. Africa Barrett Esophagus Market Attractiveness Index
11.5.1. By Country
11.5.2. By Distribution Channel
11.5.3. By Treatment
12. Recommendation
12.1. Market Strategy
13. Competitive Landscape
13.1. Competition Dashboard
13.2. List and Company Overview of Global Key Players
13.3. Company Profiles
13.3.1. Addex Therapeutics
13.3.1.1. Company Overview
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. Key Developments
13.3.1.5. Business Strategies
13.3.2. AstraZeneca Plc.
13.3.3. Rottapharm (Meda AB)
13.3.4. Takeda Pharmaceutical Company Limited
13.3.5. Eisai Co. Ltd.
13.3.6. Pfizer Inc.
13.3.7. Torax Medical
13.3.8. Mederi Therapeutics
13.3.9. Aros Pharma
13.3.10. Torax Medical, Inc.
13.3.11. C. R. Bard
14. Acronyms
